Der blev ikke rapporteret om kumulativ toksicitet med hensyn til infektioner i en behandlingsperiode på 2 år.
Higher frequencies of infections overall, including grade 3 or 4 infections, were observed during MabThera maintenance treatment up to 2 years when compared to observation. There was no cumulative toxicity in terms of infections reported over a 2-year treatment period.